Cresco Labs Inc. (CRLBF)
(Delayed Data from OTC)
$1.61 USD
+0.04 (2.55%)
Updated Jul 26, 2024 03:41 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CRLBF 1.61 +0.04(2.55%)
Will CRLBF be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CRLBF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRLBF
Universal Health Services (UHS) Q2 Earnings and Revenues Surpass Estimates
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates
CRLBF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Cresco Labs Inc. (CRLBF) Report Negative Earnings Next Week? What You Should Know
AdaptHealth Corp. (AHCO) Lags Q1 Earnings Estimates
Here's How Cresco Labs (CRLBF) is Placed Before Q1 Earnings
Other News for CRLBF
Marijuana Stock Movers For July 25, 2024
Cannabis Stock Gainers And Losers From July 24, 2024
Cresco Labs to Report Second Quarter 2024 Financial Results on August 8, 2024
Cresco Labs Announces Q2 2024 Financial Results Date
91% favor reforms as public comment period for marijuana rescheduling ends